In the first quarter of the February 2027 term, net sales reached JPY 17,034 million (YoY +123.1%), operating income JPY 2,204 million (YoY +151.7%), ordinary income JPY 2,192 million (YoY +152.4%), and net income attributable to owners of the parent JPY 1,486 million (YoY +157.2%), marking record highs. Dividend guidance was also revised. Segment-wise, Creative Japan posted JPY 10,564 million in net sales, Healthcare JPY 2,239 million, and CRES JPY 1,745 million, with continued expansion investments in other businesses.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4763","jir_company_name":"Cliff & River Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4763-20260709-01.pdf","jir_short_summary":"In the first quarter of the February 2027 term, net sales reached JPY 17,034 million (YoY +123.1%), operating income JPY 2,204 million (YoY +151.7%), ordinary income JPY 2,192 million (YoY +152.4%), and net income attributable to owners of the parent JPY 1,486 million (YoY +157.2%), marking record highs. Dividend guidance was also revised. Segment-wise, Creative Japan posted JPY 10,564 million in net sales, Healthcare JPY 2,239 million, and CRES JPY 1,745 million, with continued expansion investments in other businesses.","jir_summary":"### Overview of performance\nFor the consolidated fiscal first quarter, net sales totaled 17,034 million yen, achieving a substantial year-over-year increase of 123.1%. Operating income reached 2,204 million yen, ordinary income 2,192 million yen, and net income attributable to owners of the parent for the quarter was 1,486 million yen, all significantly exceeding the previous year and marking a record-high level of performance. By segment, Creative Japan remained solid with net sales of 10,564 million yen, Healthcare 2,239 million yen, CRES 1,745 million yen, with expansion investments continuing in other businesses.\n\n### Outlook and dividends\nConsolidated earnings outlook for the February 2027 term and dividend guidance have been revised upward, reflecting solid progress in Creative (Japan) and Healthcare segments, and also considering the Takahashi Publishing Group, which became a consolidated subsidiary in March 2025, as on track. An upward revision to the full-year forecast has been issued. Note that the revised dividend guidance is included in the public materials, so shareholder returns will continue to be a focus.","jir_financial_highlights":"Net sales: 17,034\u767e\u4e07\u5186 (YoY +123.1%)\nOperating income: 2,204\u767e\u4e07\u5186 (YoY +151.7%)\nOrdinary income: 2,192\u767e\u4e07\u5186 (YoY +152.4%)\nNet income attributable to owners of the parent for the quarter: 1,486\u767e\u4e07\u5186 (YoY +157.2%)","jir_category":"","jir_hashtags":"#CliffAndRiver, #IR, #JapanStocks","jir_key_figures":"Net sales: 17,034\u767e\u4e07\u5186\nOperating income: 2,204\u767e\u4e07\u5186\nOrdinary income: 2,192\u767e\u4e07\u5186\nNet income attributable to owners of the parent for the quarter: 1,486\u767e\u4e07\u5186\nEarnings per share for the quarter: 70.18\u5186\nFull-year net sales forecast: 66,000\u767e\u4e07\u5186 (full-year guidance exists)","jir_meta_title":"\u3010Cliff & River\u3011First Quarter Earnings \u2013 Net Sales 17,034 million yen, Record High","jir_meta_description":"Cliff & River highlights for the FY2027 February quarter. Net sales 17,034 million yen, operating income 2,204 million yen, and other key indicators with segment trends and revisions to full-year outlook.","jir_og_title":"\u3010Cliff & River\u3011First Quarter Earnings: Net Sales 17,034 million yen","jir_og_description":"First quarter earnings show net sales up 123.1% YoY to a record high. Key segment trends and revisions to full-year outlook explained.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net sales trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2Q\\\",\\\"2027\/1Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net sales\\\",\\\"data\\\":[13839,17034]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating income trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2Q\\\",\\\"2027\/1Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating income\\\",\\\"data\\\":[1453,2204]}]}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net income trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026\/2Q\\\",\\\"2027\/1Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net income attributable to owners of the parent\\\",\\\"data\\\":[945,1486]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment net sales\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Creative Japan\\\",\\\"Creative Korea\\\",\\\"Healthcare\\\",\\\"Accounting & Legal\\\",\\\"CRES\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net sales\\\",\\\"data\\\":[10564,802,2239,612,1745,1069]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Forecast vs. actual\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Q2 to-date\\\",\\\"Full-year\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net sales\\\",\\\"data\\\":[31500,66000]},{\\\"label\\\":\\\"Operating income\\\",\\\"data\\\":[2550,5450]}]}\"}]","ir_related_company":57085,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-77702","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n